Detection of pulmonary embolism with combined ventilation–perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography
…, J Mortensen, CV Jensen, CB Johnbeck… - Journal of Nuclear …, 2009 - Soc Nuclear Med
The diagnosis of pulmonary embolism (PE) is usually established by a combination of clinical
assessment, D-dimer testing, and imaging with either pulmonary ventilation–perfusion (V/Q…
assessment, D-dimer testing, and imaging with either pulmonary ventilation–perfusion (V/Q…
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature
CB Johnbeck, U Knigge, A Kjær - Future oncology, 2014 - Future Medicine
Neuroendocrine tumors have shown rising incidence mainly due to higher clinical awareness
and better diagnostic tools over the last 30 years. Functional imaging of neuroendocrine …
and better diagnostic tools over the last 30 years. Functional imaging of neuroendocrine …
Imaging macrophage and hematopoietic progenitor proliferation in atherosclerosis
…, V Mani, S Ishino, CB Johnbeck… - Circulation …, 2015 - Am Heart Assoc
Rationale: Local plaque macrophage proliferation and monocyte production in hematopoietic
organs promote progression of atherosclerosis. Therefore, noninvasive imaging of …
organs promote progression of atherosclerosis. Therefore, noninvasive imaging of …
18F-FDG PET is superior to WHO grading as a prognostic tool in neuroendocrine neoplasms and useful in guiding PRRT: a prospective 10-year follow-up study
T Binderup, U Knigge, CB Johnbeck… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Accurate grading of patients with neuroendocrine neoplasms (NENs) is essential for risk
stratification and optimal choice of therapy. Currently, grading is based on histologically …
stratification and optimal choice of therapy. Currently, grading is based on histologically …
Semiautomatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion …
EA Carlsen, CB Johnbeck, M Loft… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Patients with neuroendocrine neoplasms (NENs) have heterogeneous somatostatin
receptor expression, with highly differentiated lesions having higher expression. Receptor …
receptor expression, with highly differentiated lesions having higher expression. Receptor …
[HTML][HTML] A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms
…, M Gæde, CN Ladefoged, M Loft, CB Johnbeck… - EJNMMI research, 2022 - Springer
Background Segmentation of neuroendocrine neoplasms (NENs) in [ 64 Cu]Cu-DOTATATE
positron emission tomography makes it possible to extract quantitative measures useable …
positron emission tomography makes it possible to extract quantitative measures useable …
64Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms
EA Carlsen, CB Johnbeck, T Binderup… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Overexpression of somatostatin receptors (SSTRs) in patients with neuroendocrine neoplasms
(NENs) is used for both diagnosis and treatment. Receptor density may reflect tumor …
(NENs) is used for both diagnosis and treatment. Receptor density may reflect tumor …
PET/MRI in cancer patients: first experiences and vision from Copenhagen
…, L Borgwardt, J Löfgren, CB Johnbeck… - … Resonance Materials in …, 2013 - Springer
Combined PET/MRI systems are now commercially available and are expected to change
the medical imaging field by providing combined anato-metabolic image information. We …
the medical imaging field by providing combined anato-metabolic image information. We …
[HTML][HTML] 18F-FDG and 18F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in …
C Bardram Johnbeck, M Munk Jensen… - PloS one, 2014 - journals.plos.org
Introduction The mTOR inhibitor everolimus has shown promising results in some but not all
neuroendocrine tumors. Therefore, early assessment of treatment response would be …
neuroendocrine tumors. Therefore, early assessment of treatment response would be …
18F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective …
T Binderup, U Knigge, CB Johnbeck… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Accurate grading of patients with neuroendocrine neoplasms (NENs) is essential for risk
stratification and optimal choice of therapy. Currently, grading is based on histologically …
stratification and optimal choice of therapy. Currently, grading is based on histologically …